Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans

被引:58
|
作者
Woelkart, K
Koidl, C
Grisold, A
Gangemi, JD
Turner, RB
Marth, E
Bauer, R
机构
[1] Graz Univ, Inst Pharmazeut Wissensch, Dept Pharmacognosy, A-8010 Graz, Austria
[2] Univ Med, Inst Hyg, Graz, Austria
[3] Clemson Univ, Inst Nutraceut Res, Clemson, SC USA
[4] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 06期
关键词
Echinacea angustifolia; alkamides; bioavailability; pharmacokinetics;
D O I
10.1177/0091270004273493
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alkamides are suspected to contribute to the activity of Echinacea preparations. They are mainly derived from undeca- and dodecanoic acid and differ in the degree of unsaturation and the configuration of the double bonds. In total, 6 alkamides have been isolated from the roots of Echinacea angustifolia as major lipophilic constituents and have been investigated regarding their pharmacokinetics. A sensitive and specific method has been developed for the identification and quantification of these alkamides in human plasma using liquid chromatography electrospray ionization ion-trap mass spectrometry. The method was applied to analyze plasma samples obtained from a randomized, open, single-dose, crossover study after oral administration of a 60% ethanolic extract from the roots of E. angustifolia to 11 healthy subjects. The maximum concentration of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides, the main alkamides in the roots of E. angustifolia, appeared already after 30 minutes and was 10.88 ng/mL for the 2.5-mL dose.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 50 条
  • [1] ALKAMIDES FROM THE ROOTS OF ECHINACEA-ANGUSTIFOLIA
    BAUER, R
    REMIGER, P
    WAGNER, H
    PHYTOCHEMISTRY, 1989, 28 (02) : 505 - 508
  • [2] NEW ALKAMIDES FROM ECHINACEA-ANGUSTIFOLIA AND ECHINACEA-PURPUREA ROOTS
    BAUER, R
    REMIGER, P
    WAGNER, H
    PLANTA MEDICA, 1988, (06) : 563 - 564
  • [3] The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots
    Woelkart, K
    Xu, W
    Pei, Y
    Makriyannis, A
    Picone, RP
    Bauer, R
    PLANTA MEDICA, 2005, 71 (08) : 701 - 705
  • [4] ALKAMIDES FROM THE ROOTS OF ECHINACEA-PURPUREA
    BAUER, R
    REMIGER, P
    WAGNER, H
    PHYTOCHEMISTRY, 1988, 27 (07) : 2339 - 2342
  • [5] Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium roots
    Laasonen, M
    Wennberg, T
    Harmia-Pulkkinen, T
    Vuorela, H
    PLANTA MEDICA, 2002, 68 (06) : 572 - 574
  • [6] Bioavailability of Echinacea alkamides in human breast milk
    Matthias, A.
    Merika, H.
    Addison, R. S.
    Bone, K. M.
    Lehmann, R. P.
    PLANTA MEDICA, 2008, 74 (09) : 921 - 921
  • [7] Alkamides from echinacea angustifolia roots inhibit cyclooxygenase-2-dependent prostaglandin synthesis in human neuroglioma cells
    Woelkart, K.
    Bauer, R.
    Hinz, B.
    PLANTA MEDICA, 2006, 72 (11) : 1062 - 1062
  • [8] Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans
    Woelkart, Karin
    Dittrich, Peter
    Beubler, Eckhard
    Pinl, Fritz
    Schoop, Roland
    Suter, Andy
    Bauer, Rudolf
    PLANTA MEDICA, 2008, 74 (06) : 651 - 656
  • [9] Macrophage activating effects of new alkamides from the roots of Echinacea species
    Chen, Y
    Fu, T
    Tao, T
    Yang, JH
    Chang, Y
    Wang, MH
    Kim, L
    Qu, LP
    Cassady, J
    Scalzo, R
    Wang, XP
    JOURNAL OF NATURAL PRODUCTS, 2005, 68 (05): : 773 - 776
  • [10] Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors
    Hohmann, Judit
    Redei, Dora
    Forgo, Peter
    Szabo, Pal
    Freund, Tamas F.
    Haller, Jozsef
    Bojnik, Engin
    Benyhe, Sandor
    PHYTOCHEMISTRY, 2011, 72 (14-15) : 1848 - 1853